Insiders: The top 20 rare disease specialists spotlight key biotech trends behind the boom
Image: Biogen CEO Michel Vounatsos at the company’s offices in Cambridge, MA on Jan. 3, 2017. The Boston Globe via Getty
Some of the most interesting ongoing discussions in biotech are focused on a few key points: how do you create value, which companies are creating the greatest value and where is the next Biogen or Celgene coming from?
This piece is for all of you who care to know more about that.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.